FDA CDER director Patrizia Cavazzoni announces resignation
Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.
Corporate Governance
Eli Lilly’s UK life sciences investment ‘a pivotal moment’, says analyst
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
Vifor Pharma offers £23m to NHS to resolve CMA investigation
FDA shares new draft guidance for accelerated approval
Merus’ Bizengri granted FDA accelerated approval to treat NRG1+ cancers
Trump 2.0 could see a rise in biopharmaceutical M&A deals
Trump 2.0 spells global change in pharmaceutical regulation, funding and investment
